The prevalence and outcome of short-acting β2-agonists overuse in asthma patients in Taiwan
Crossref DOI link: https://doi.org/10.1038/s41533-021-00231-1
Published Online: 2021-04-20
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Wang, Cheng-Yi
Lai, Chih-Cheng http://orcid.org/0000-0002-6334-2388
Wang, Ya-Hui
Wang, Hao-Chien
Text and Data Mining valid from 2021-04-20
Version of Record valid from 2021-04-20
Article History
Received: 22 July 2020
Accepted: 17 February 2021
First Online: 20 April 2021
Competing interests
: H.-C.W. received grants from AstraZeneca Taiwan. The remaining authors declare no competing interests.